Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01793792
Other study ID # CL11002
Secondary ID G110188/S004
Status Completed
Phase N/A
First received
Last updated
Start date July 2013
Est. completion date January 2016

Study information

Verified date November 2019
Source Microvention-Terumo, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of the Low Profile Visualized Intraluminal Support(LVIS™ and LVIS™ Jr.)devices from MicroVention, Inc. when used to facilitate endovascular coiling of wide-necked intracranial aneurysms with coils.


Recruitment information / eligibility

Status Completed
Enrollment 153
Est. completion date January 2016
Est. primary completion date November 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Subject age between 18 and 75 years

- Subject with an unruptured or ruptured(>30days since occurence), wide-necked (neck =4mm or dome to neck ratio <2)intracranial saccular aneurysm (<20mm maximum diameter in any plane)

Exclusion Criteria:

- Subject with significant extra or intracranial stenosis of the parent artery (>50%) proximal to the target aneurysm.

- Subject with any condition which in the opinion of the treating physician would place the subject at high risk of embolic stroke

- Subject with contraindications to the use of antiplatelet agents

- Subject who is unable to complete the required follow-up

Study Design


Related Conditions & MeSH terms


Intervention

Device:
LVIS™ and LVIS™ Jr
The LVIS Device is intended for use with embolization coils for the treatment of wide neck, intracranial aneurysms.

Locations

Country Name City State
United States Albany Medical College Albany New York
United States University of Maryland Baltimore Maryland
United States Tufts Medical Center Boston Massachusetts
United States University at Buffalo Neurosurgery Buffalo New York
United States Dignity Health/Mercy San Juan Medical Center Carmichael California
United States Medical University of South Carolina Charleston South Carolina
United States Rush University Medical Center Chicago Illinois
United States Cleveland Clinic Foundation Cleveland Ohio
United States Colorado Neurological Institute Englewood Colorado
United States The Methodist Hospital Houston Texas
United States Indiana University/Methodist Research Institute Indianapolis Indiana
United States North Shore University Hospital Manhasset New York
United States Methodist University Hospital Memphis Tennessee
United States Abbott Northwestern Hospital Minneapolis Minnesota
United States University of Minnesota Minneapolis Minnesota
United States Vanderbilt University Nashville Tennessee
United States St. Luke's Roosevelt Hospital Center New York New York
United States Advocate Health and Hospital Oak Lawn Illinois
United States St. Joseph's Hospital and Medical Center Phoenix Arizona
United States University of Pittsburgh Medical Center Pittsburgh Pennsylvania
United States Stony Brook University Medical Center Stony Brook New York

Sponsors (1)

Lead Sponsor Collaborator
Microvention-Terumo, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary Effectiveness Composite Success "Number of Participants With Primary Effectiveness Composite Success (100% Aneurysm Occlusion Without Clinically Significant In-stent Stenosis or Target Aneurysm Retreatment" 12 months
Primary Primary Safety Composite Rate (Disabling Stroke With mRS Score Greater Than or Equal to 3, or Neurological Death Within 12 Months 12 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02879175 - Patients' Follow-up After Subarachnoid Haemorrhage Caused by Ruptured Intracranial Aneurysms
Completed NCT01139892 - The Canadian UnRuptured Endovascular Versus Surgery Trial (CURES)
Recruiting NCT06411418 - Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm N/A
Completed NCT02312856 - Adjunctive Neurovascular Support for Wide-neck Aneurysm Embolization and Reconstruction N/A
Recruiting NCT01054391 - Neurovascular Embolization Cover for Treatment of Intracranial Aneurysms and Carotid/Vertebrobasilar Fistulae N/A
Completed NCT02657772 - Ultra Coils From Start to Finish for the Endovascular Repair of Small Intracranial Aneurysms
Completed NCT01465841 - Study of the Penumbra Coil 400 System to Treat Aneurysm N/A
Enrolling by invitation NCT05453240 - Post-Market Surveillance Study to Evaluate the Long-Term Safety and Effectiveness of the LVIS Device
Completed NCT03550638 - Coil System(Ton-bridgeMT) for Endovascular Embolization of Cranial Aneurysms N/A
Terminated NCT02122133 - CARE: A Prospective Multicenter Case Study to Assess Radiation Exposure in Patients Treated With the Penumbra Coil 400
Completed NCT01541254 - Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device Phase 2/Phase 3
Terminated NCT01320306 - Intracranial Aneurysms and Cognitive Function
Recruiting NCT01084681 - Efficacy Trial of Intracranial Aneurysm Treatment Using Two Different Endovascular Techniques N/A
Completed NCT00396981 - MAPS Trial: Matrix And Platinum Science Phase 4
Completed NCT02921711 - TRAIL: Treatment of Intracranial Aneurysms With LVIS® System
Recruiting NCT01031147 - Contrast-free Magnetic Resonance Angiography (MRA) at 3.0 T for Intracranial Aneurysm Detection N/A
Recruiting NCT05636124 - Kaneka iED Coil System for the Treatment of Wide Necked Ruptured and Unruptured Intracranial Aneurysms N/A
Completed NCT02921698 - Safety and Efficacy Analysis of FRED® Embolic Device in Aneurysm Treatment
Terminated NCT01974700 - Seizure Prophylaxis in Aneurysm Repair Phase 4
Completed NCT01801007 - Pivotal Study of the FRED Stent System in the Treatment of Intracranial Aneurysms N/A